Bristol Myers Squibb (BMY) Com Stk USD 0.10 (CDI)

Sell:$59.52Buy:$59.53$1.48 (2.43%)

Prices delayed by at least 15 minutes
Sell:$59.52
Buy:$59.53
Change:$1.48 (2.43%)
Deal now
Prices delayed by at least 15 minutes
Sell:$59.52
Buy:$59.53
Change:$1.48 (2.43%)
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

Bristol-Myers Squibb Company is a global biopharmaceutical company. It is engaged in the discovery, development and delivery of transformational medicines for patients facing serious diseases in areas: oncology, hematology, immunology, cardiovascular, neuroscience and other areas. Its platforms comprise chemically synthesized or small molecule drugs, including protein degraders; drugs produced from biological processes, called biologics; ADCs, CAR-T cell therapies, and radiopharmaceutical therapeutics. Small molecule drugs are typically administered orally in the form of a tablet or capsule, although other drug delivery mechanisms are also used. Biologics are typically administered through injections or by intravenous infusion. CAR-T cell therapies are administered by intravenous infusion. Its growth portfolio includes Opdivo, Opdivo Qvantig, Orencia, Yervoy, Reblozyl, Opdualag, and others. Its legacy portfolio includes Eliquis, Revlimid, Pomalyst/Imnovid, Sprycel and Abraxane.

Key people

Christopher S. Boerner
Chairman of the Board, Chief Executive Officer, Chief Operating Officer
David V. Elkins
Executive Vice President, Chief Financial Officer, Member of the Leadership Team
Lynelle Hoch
President, Cell Therapy Organization, Member of the Leadership Team
Amanda Poole
Chief Human Resource Officer, Executive Vice President, Member of the Leadership Team
Greg Scott Meyers
Executive Vice President, Chief Digital and Technology Officer, Member of the Leadership Team
Sandra Leung
Executive Vice President, General Counsel, Member of the Leadership Team
Cari Gallman
Executive Vice President, Corporate Affairs, Member of the Leadership Team
Samit Hirawat
Executive Vice President, Chief Medical Officer, Head of Development, Member of the Leadership Team
Adam Lenkowsky
Executive Vice President, Chief Commercialization Officer, Member of the Leadership Team
Robert Plenge
Executive Vice President, Chief Research Officer, Head of Research, Member of the Leadership Team
Theodore R. Samuels
Lead Independent Director
Peter J. Arduini
Independent Director
Deepak L. Bhatt
Independent Director
Julia A. Haller
Independent Director
Michael R. Mcmullen
Independent Director
Click to see more

Key facts

  • EPIC
    BMY
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    US1101221083
  • Market cap
    $122.13bn
  • Employees
    34,100
  • Shares in issue
    2.93bn
  • Exchange
    New York Stock Exchange
  • Index
    S&P 500, TR Equity United States Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.